Paratek And The “Blockbuster” vs. Steady “Stewardship” Approach In Antibiotics

US FDA Antimicrobial Drugs Advisory Committee Chair Baden offers warning about “overuse” to emerging antibiotic sponsor.

Antibiotic resistant bacteria closeup biofilm

More from US FDA Performance Tracker

More from Regulatory Trackers